Recent Concept for Management of Legg-Calve'-Perthes disease
6 Angebote vergleichen
Bester Preis: € 31,51 (vom 16.03.2019)1
Recent Concept for Management of Legg-Calve -Perthes disease
DE NW
ISBN: 9783330024274 bzw. 3330024275, in Deutsch, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Lieferzeit: 11 Tage.
This book is very important for the orthopaedic surgeons because it discusses the up-to date information about the Recent Concept for the Management of Legg-Calve -Perthes disease. This book has many illustrative figures and follow-up x-rays that make the diagnosis, classifications and the treatment principles easily tailored according to the different circumstances of every case. The author discusses and summarized the advantages and the disadvantages of every method and highlighted on the most recent concept about the pathology and the treatment which is Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand. RANKL is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL has been identified to affect the immune system and control bone regeneration and remodeling. Not to be confused with RANK, the osteoclast cell-surface receptor that binds to RANKL. So, the Anti resorptive drugs has new role in the treatment of the disease.
This book is very important for the orthopaedic surgeons because it discusses the up-to date information about the Recent Concept for the Management of Legg-Calve -Perthes disease. This book has many illustrative figures and follow-up x-rays that make the diagnosis, classifications and the treatment principles easily tailored according to the different circumstances of every case. The author discusses and summarized the advantages and the disadvantages of every method and highlighted on the most recent concept about the pathology and the treatment which is Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand. RANKL is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL has been identified to affect the immune system and control bone regeneration and remodeling. Not to be confused with RANK, the osteoclast cell-surface receptor that binds to RANKL. So, the Anti resorptive drugs has new role in the treatment of the disease.
2
Recent Concept for Management of Legg-Calve-Perthes disease
DE PB NW
ISBN: 9783330024274 bzw. 3330024275, in Deutsch, LAP Lambert Academic Publishing, Taschenbuch, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Recent Concept for Management of Legg-Calve-Perthes disease: This book is very important for the orthopaedic surgeons because it discusses the up-to date information about the Recent Concept for the Management of Legg-Calve -Perthes disease. This book has many illustrative figures and follow-up x-rays that make the diagnosis, classifications and the treatment principles easily tailored according to the different circumstances of every case. The author discusses and summarized the advantages and the disadvantages of every method and highlighted on the most recent concept about the pathology and the treatment which is Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand. RANKL is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL has been identified to affect the immune system and control bone regeneration and remodeling. Not to be confused with RANK, the osteoclast cell-surface receptor that binds to RANKL. So, the Anti resorptive drugs has new role in the treatment of the disease. Englisch, Taschenbuch.
Recent Concept for Management of Legg-Calve-Perthes disease: This book is very important for the orthopaedic surgeons because it discusses the up-to date information about the Recent Concept for the Management of Legg-Calve -Perthes disease. This book has many illustrative figures and follow-up x-rays that make the diagnosis, classifications and the treatment principles easily tailored according to the different circumstances of every case. The author discusses and summarized the advantages and the disadvantages of every method and highlighted on the most recent concept about the pathology and the treatment which is Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand. RANKL is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL has been identified to affect the immune system and control bone regeneration and remodeling. Not to be confused with RANK, the osteoclast cell-surface receptor that binds to RANKL. So, the Anti resorptive drugs has new role in the treatment of the disease. Englisch, Taschenbuch.
3
Recent Concept for Management of Legg-Calve´-Perthes disease
DE HC NW
ISBN: 9783330024274 bzw. 3330024275, in Deutsch, Lap Lambert Academic Publishing, gebundenes Buch, neu.
Lieferung aus: Deutschland, Versandkostenfrei innerhalb von Deutschland.
This book is very important for the orthopaedic surgeons because it discusses the up-to date information about the Recent Concept for the Management of Legg-Calve -Perthes disease. This book has many illustrative figures and follow-up x-rays that make the diagnosis, classifications and the treatment principles easily tailored according to the different circumstances of every case. The author discusses and summarized the advantages and the disadvantages of every method and highlighted on the most This book is very important for the orthopaedic surgeons because it discusses the up-to date information about the Recent Concept for the Management of Legg-Calve -Perthes disease. This book has many illustrative figures and follow-up x-rays that make the diagnosis, classifications and the treatment principles easily tailored according to the different circumstances of every case. The author discusses and summarized the advantages and the disadvantages of every method and highlighted on the most recent concept about the pathology and the treatment which is Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand. RANKL is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL has been identified to affect the immune system and control bone regeneration and remodeling. Not to be confused with RANK, the osteoclast cell-surface receptor that binds to RANKL. So, the Anti resorptive drugs has new role in the treatment of the disease. Lieferzeit 1-2 Werktage.
This book is very important for the orthopaedic surgeons because it discusses the up-to date information about the Recent Concept for the Management of Legg-Calve -Perthes disease. This book has many illustrative figures and follow-up x-rays that make the diagnosis, classifications and the treatment principles easily tailored according to the different circumstances of every case. The author discusses and summarized the advantages and the disadvantages of every method and highlighted on the most This book is very important for the orthopaedic surgeons because it discusses the up-to date information about the Recent Concept for the Management of Legg-Calve -Perthes disease. This book has many illustrative figures and follow-up x-rays that make the diagnosis, classifications and the treatment principles easily tailored according to the different circumstances of every case. The author discusses and summarized the advantages and the disadvantages of every method and highlighted on the most recent concept about the pathology and the treatment which is Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand. RANKL is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL has been identified to affect the immune system and control bone regeneration and remodeling. Not to be confused with RANK, the osteoclast cell-surface receptor that binds to RANKL. So, the Anti resorptive drugs has new role in the treatment of the disease. Lieferzeit 1-2 Werktage.
4
Recent Concept for Management of Legg-Calve'-Perthes disease
DE PB NW
ISBN: 3330024275 bzw. 9783330024274, in Deutsch, LAP Lambert Academic Publishing, Taschenbuch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
5
Recent Concept for Management of Legg-Calve´-Perthes disease (2016)
EN PB NW FE
ISBN: 9783330024274 bzw. 3330024275, in Englisch, 64 Seiten, LAP LAMBERT Academic Publishing, Taschenbuch, neu, Erstausgabe.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Usually dispatched within 24 hours.
Von Händler/Antiquariat, Amazon.co.uk.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, Amazon.co.uk.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
6
Recent Concept for Management of Legg-Calve´-Perthes disease (2017)
DE PB NW
ISBN: 9783330024274 bzw. 3330024275, in Deutsch, Taschenbuch, neu.
Lieferung aus: Deutschland, Next Day, Versandkostenfrei.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…